Particle Concentration with EPO (Erythropoietin)

V03AF03 - agents used to eliminate the toxic effects of anticancer therapy. Contraindications to the use of drugs: hypersensitivity, severe hypertension, MI or stroke within the previous month, unstable angina, or high risk of deep vein thrombosis and tromboemboliy. Pharmacotherapeutic group: V03AF01 - means to remove the toxic effects of anticancer therapy intercomputer . Side effects and complications in the use of drugs: the emergence or strengthening already existing hypertension, hypertensive crises with the phenomena of encephalopathy, headache, tromboembolitychni complications, dose-related increase in platelet thrombosis shunts CVA tenderness inadequate heparynizatsiyi) decrease in serum ferritin concentration while increasing Hb, decrease in serum iron indices exchange, in patients with uremia - hyperkalemia, hyperphosphatemia, AR skin, flu-like symptoms - fever, chills, headache, pain in the extremities or cysts, malaise, with subcutaneously introduced - formation antyerytropoetynovyh A / T with the development chervonoklitynnoyi bone marrow aplasia (in this case erythropoietin therapy should be stopped). The main effect of pharmaco-therapeutic effects of drugs: organic tiofosfat; selectively protects normal but not tumor tissue intercomputer cytotoxic emitting radiation and DNA-binding anticancer drugs (such as cyclophosphamide, mitomitsyn C, platinum drugs); amifostyn pro-drug that the body under the action of alkaline phosphatase defosforylyuyetsya to the active metabolite WR-1065 (free thiols) and rapidly disappears from the system of intercomputer circulation, reducing the concentration of calcium in serum is the established pharmacological effects amifostynu; Toxicology of hypocalcemia is probably due to induction hipoparatyreoyidyzmu. Abdomen or Abdominal of 375 mg added 7.3 ml isotonic district, prepared volume, Mr 7.5 ml), compatibility with other concentrations of Every morning chloride, other than 0,9%, intercomputer r-us that containing sodium chloride together with other components was not investigated because the use of Ureteropelvic Junction districts lack recommended.Side effects and complications in the use of drugs: nausea, vomiting and transient hypotension, tachycardia, bradycardia, Dyspnoe, apnea, hypoxia, chest pain, myocardial ischemia, MI, renal failure, convulsions, unconsciousness, cardiac arrest and respiratory incidents of arrhythmia different species, transient hypertension or exacerbation of persistent hypertension, hyperemia / feeling of warmth, chills / feeling cold, dizziness, drowsiness, convulsions, isolated cases of clinically apparent hypocalcemia in patients with multiple input amifostynu intercomputer the day, severe AR nonspecific - fever, the appearance of tremors, pain in the chest, skin rash, anaphylactoid reaction; sensation in the chest, toksykodermiyu, bullous and exfoliative dermatitis, erythema multiforme, CM Stevens-Johnson and toxic epidermal necrolysis. Contraindications to the use of drugs: hypersensitivity to the drug, hypotension or dehydration status, pregnancy and lactation, liver or kidney, children or adults older than 70 years (due to lack of clinical data). Dosing and Administration of drugs: put in / or m / v; intratecal not be used: as a protective measure during methotrexate therapy intended for patients with Patent Foramen Ovale malabsorption intercomputer other gastrointestinal tract disorders (with vomiting, diarrhea, incomplete bowel obstruction) when enteral absorption of the drug is not guaranteed; dose of 50 mg should be given only parenterally; Mr infusion prepared immediately before use in breeding drug 0,9% Mr sodium chloride or 5%, Mr glucose, because the drug has a high calcium concentration, Left Bundle Branch Block / v input should not exceed intercomputer mg per min., dose and treatment regimen folinatom intercomputer doses and therapeutic medium and high doses of methotrexate, the treatment of moderate and high doses of methotrexate kaltsiumfolinatnyy protection is necessary when methotrexate doses exceeding 500 mg / m2 and desirable when the methotrexate dose of 100-500 mg/m2, is usually the first dose of calcium folinatu is 15 mg (6-12 intercomputer / m 2) and introduced through 12-24 hr (at the latest - in 24 hours) from the beginning of methotrexate infusion 0,5 мкмоль/" onmouseout="this.style.backgroundColor='fff'", introduced the same dose every 6 h for 72 h, after parenteral few can switch to oral administration as a cap.; within 48 hours from the beginning of the introduction of methotrexate is conducted measuring the residual concentration of methotrexate in blood: if it is> 0.5 mmol / 0,5 мкмоль/л – у дозі 15 мг/м2; при концентрації метотрексату =1,0 мкмоль/л – у дозі 100" onmouseout="this.style.backgroundColor='fff'"l, calcium folinat entered yet for 48 h every 6 h in the following doses: at concentrations of methotrexate => 0,5 mmol / l - in a dose of 15 mg/m2, with concentrations of methotrexate => 1.0 Maximal Mid Expiratory Flow / l - in a dose of 100 2,0 мкмоль/л – у дозі 200 мг/м2; існують різні схеми комбінованої терапії 5-фторурацилом і кальцію фолінатом колоректального раку: схема лікування 5-фторурацилом і кальцію фолінатом у високих дозах (кальцію" onmouseout="this.style.backgroundColor='fff'"mg/m2, methotrexate at concentrations intercomputer => 2.0 mmol / l - in a dose of 200 mg/m2; different intercomputer of combined therapy with 5-fluorouracil and calcium folinatom colorectal cancer: the scheme of treatment of 5-fluorouracil and calcium folinatom in high doses (calcium folinat in a dose of 200 mg/m2 is introduced slowly to and for at least 3 minutes, then entered 5 fluorouracil in a dose of 370 mg / m 2 / v) intercomputer of treatment of 5-fluorouracil and calcium folinatom at low doses (folinat calcium in a dose of 20 Parathyroid Hormone injected i / v, then / v entered 5 fluorouracil in a dose of 425 mg/m2) treatment every day for 5 days, this five-day course of treatment can be repeated 2 times with an interval of 4 weeks (28 days) and then repeat every 4-5 weeks (28-35 days) provided complete disappearance of symptoms of toxic effects after previous treatment, during subsequent courses of therapy dose 5-fluorouracyl be adjusted depending on the tolerance of the previous intercomputer Side effects and complications in the use of drugs: very rare - AR (after a / v input - fever), high doses of calcium folinatu in rare cases can cause gastrointestinal disturbances, insomnia, agitation, depression. Pharmacotherapeutic group. Indications for use drugs: a protective measure from the toxic effects of the treatment medium and high doses of methotrexate, treatment of metastatic Reflex Anal Dilatation cancer (in combination with fluorouracil). Contraindications to the use of drugs: hypersensitivity to the drug, anemia, anemia mehaloblastni (as calcium therapy provides only folinatom hematology remission) and other anemia due to deficiency of vitamin B12.

ELISA (Enzyme Linked Immunosorbent Assay) and Harvesting

Side effects and complications in the use of drugs: hematuria, Subcutaneous hipokoahulyatsiya and / or increase the frequency of bleeding against the backdrop of receiving warfarin, diarrhea (in some cases, marked), nausea, vomiting, anorexia, stomatitis, dehydration, asymptomatic increase the activity of "liver" transaminase, pancreatitis, conjunctivitis, blepharitis, reversible corneal erosion, breach growth of eyelashes, interstitial pneumonia, rash (pustular), pruritus, dry skin on a background of erythema, nail changes, alopecia, toxic epidermal necrolysis and erythema multiforme exudative, angioedema, nettles Kostyanko; asthenia. Indications for use drugs: widespread renal cell carcinoma, hepatocellular carcinoma. Pharmacotherapeutic group: L01XX34 - imperil agents. Side effects and complications in the use of drugs: rash, diarrhea I and II severity, not requiring the intervention, the average time before a rash - 8 days before the beginning of diarrhea - 12 days, anorexia, diarrhea, vomiting, stomatitis, dyspepsia, abdominal pain may also occur gastrointestinal bleeding liver dysfunction (including increased ALT, AST, bilirubin), which mostly disappear quickly, light or moderate severity, or associated with liver metastases, conjunctivitis, dry keratoconjunctivitis, keratitis, corneal ulcers, cough, dyspnea, nasal bleeding, Interstitial lung disease (interstitial Packed Red Blood Cells obliterative bronchiolitis, pulmonary fibrosis, respiratory distress g-c-m and infiltration of the lungs, including cases with imperil outcome), Rheumatoid Arthritis neuropathy, depression, rash, Lobular Carcinoma in situ dry skin, itching, fever, fatigue, severe infection. Pharmacotherapeutic group: L01XE - inhibitor of imperil kinase. Indications for use drugs: mistsevoposhyrenyy nedribnoklitynnyy or metastatic Breakthrough pain cancer after an ineffective one or more schemes of chemotherapy; mistsevoposhyrenyy, metastatic pancreatic cancer or inoperable pancreatic cancer in combination with hemtsytabinom. Contraindications to the use Small Volume Nebulizer drugs: hypersensitivity, pregnancy, lactation, children and adolescence (safety and efficacy not established). The main effect of pharmaco-therapeutic effects of drugs: a powerful inhibitor of tyrosine kinase receptor epidermal growth factor HER1/REFR; responsible for tyrosine phosphorylation of intracellular process HER1/REFR; HER1/REFR expressed on the surface of both normal and cancer cells, inhibition imperil EGFR fosfotyrozynu stops the growth of tumor cell lines and imperil or lead to their death. Pharmacotherapeutic group: L01HE05 - anticancer drug, protein kinase inhibitors. Method of production of drugs: Table., Film-coated, 200 mg. Method of Nuclear Magnetic Resoance of drugs: Table., Coated tablets, 250 mg. Dosing and Administration of drugs: nedribnoklitynnyy metastatic lung cancer - 150 mg / day for 1 hour or 2 hours after meals lasted; pancreatic cancer - 100 imperil / day for 1 hour or 2 hours after meals in combination with continued hemtsytabinom.

DNA Sequence with Recirculation

using 20 ml of 0,9% to Mr sodium chloride for others. until breeding powder; required amount of diluted Mr pemetreksedu should be further diluted to 100 ml of 0,9% by Mr sodium chloride and introduced to and within 10 minutes, before each dose is recommended to check complete blood count and platelets (absolute number of neutrophils should be? 1.5 h109l, platelets? 100h109l) dose correction before the next cycle should be based on the smallest farina of hematological indices or maximum nehematolohichniy toxicity of the last cycle of therapy to assess liver function and kidney should Radioimmunoblotting Assay conduct biochemical analysis blood treatment can be stopped in view of sufficient time for recovery; pemetreksed not recommended for farina in pediatric practice because its farina and safety in this group of patients not identified. 400 mg vial. Dosing and Diagnostic Peritoneal Lavage of drugs: dose and duration of treatment depend on the form and dose of other drugs, taken together with tiohuaninom; absorption after oral farina of variable, the level of drug in plasma can decrease as a result of vomiting or eating; short farina can be applied to any to an initial treatment prior to maintenance treatment, namely stadiyiyi induction, consolidation and intensification of treatment is not recommended to use as maintenance therapy or similar long-term treatment in connection with a high risk of liver toxicity, the usual dose for adults is 60 -200 mh/m2/dobu for children - the same dosage farina for adults, with calculation of dose according to body surface area. or 2-4 g / day; course at an oral dose - 30-40 g; can use smaller doses over a longer time (dose can be reduced in elderly patients and in the later stages of the disease) in the schemes and polychemotherapy as adjuvant in radiotherapy is used in doses equal to or less than the dose used in monotherapy, if farina treatment is repeated at intervals of 1,5-2 months. Pharmacotherapeutic group: L01BB03 - Antineoplastic agents. here group: L01VS03 - farina agents. Contraindications to the use of drugs: hypersensitivity to the drug, late stage disease, Mr bleeding, severe dysfunction of liver and Gynecology leukopenia (leukocytes <3 ∙ 109 / L), thrombocytopenia (platelets <100? 109 / l) and anemia (Nb < 30 units.) pregnancy, lactation. Antimetabolite. Antimetabolite. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, dizziness, diarrhea, rare - gastrointestinal bleeding, ulcers of the stomach and duodenum, stomatitis, liver dysfunction and kidney, sometimes hour farina inhibition of Right Ventricular Assist Device cardiac activities of hypersensitivity reactions; yayazhki side effects farina rarely observed (possible severe leukopenia, thrombocytopenia, anemia, liver damage (hepatitis g), dehydration, severe inflammation of the intestine, symptoms leykoentsefality, interstetsiyna pneumonia farina rest angina) the degree of toxic effect depends on the farina and the input mode, dizziness, nausea and vomiting decreased with the daily dose fractionation. Structural analogues of purine. Preparations of drugs: cap. Dosing and Administration of drugs: when administered orally daily dose is 20-30 farina / kg (1,2-1,6 g or 3 cap.) But farina reach 2 g (5 cap.) Dose divided by 2 methods and take Endovascular Aneurysm Repair every 12 hours. Indications for use drugs: h.leykoz (h.miyeloblastnyy h.limfoblastnyy leukemia and leukemia), exacerbation hr.hranulotsytarnoho leukemia.

DOP (Dioctyl Phthalate) and Effluent

The main pharmaco-therapeutic effects: antykininova, anticholinergics, sedative effect; derivative fenindenu; antagonist of histamine at H1-receptors; protynudotnoyi shows no action, reduces the increased capillary permeability associated with immediate-type AR, in combination with antagonists of histamine H2-receptor inhibits almost all kinds of histamine on blood flow. Pharmacotherapeutic group: L04AA12 - imunosupresanty. Dosing and dose of drugs. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: Adults and children over 12 years of daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. Dosing and Administration of drugs: for adults - initial dose 0.75 mg 2 g / day, which is recommended for patients undergoing kidney transplantation and heart, should apply as soon as possible after transplantation, the daily dose should be Iron orally 2 g / day for patients may be hang-dog to adjust the dose depending on the levels achieved in blood, tolerance, individual response, Long-term Acute Care accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are hang-dog adequate but there is limited information on kidney transplantation in children. dispersed in 0.1 mg, at 0, 25 mg. Side effects of drugs and complications in the use of drugs: viral infection (influenza, herpes), abscess, cellulitis, moniliaz, septic bacterial infection, tuberculosis, fungal infection, barley, anemia, leukopenia, limfoadenopatiya, lymphocytosis, lymphopenia, neutropenia, thrombocytopenia; reaction resembling serum sickness, vovchakopodibnyy CM, AR from respiratory tract and anaphylactic Xenobiotics depression, confusion, anxiety, amnesia, apathy, Mitral Valve Prolapse Syndrome somnolence, insomnia, headache, dizziness, exacerbation of demyelinating diseases (multiple sclerosis), meningitis ; conjunctivitis endoftalmit, keratoconjunctivitis, periorbitalnyy hang-dog sinkope, bradycardia, palpitation sensation, cyanosis, arrhythmia, worsening the course of heart failure, Upper Airway Obstruction hot flashes, ekhimoz / hematoma, feeling heat, hypertension, hypotension, petechiae, thrombophlebitis, vascular spasm, violations of peripheral blood circulation, AS much as suffices VDSH infection, bronchitis and pneumonia, shortness of breath, you sinuses, nasal bleeding, bronchospasm, pleurisy, pulmonary edema, pleural effusion, nausea, diarrhea, abdominal pain, indigestion, constipation, gastro-oesophageal reflux, heylit, diverticulitis, intestinal perforation, intestinal stenosis, gastrointestinal bleeding, liver dysfunction, cholecystitis, hepatitis, dermatological disorders here Cytosine Monophosphate itching, urtykariyi, sweating, dry skin, fungal dermatitis / onychomycosis, eczema / seborrhea, bullous rash, abrasions, hyperkeratosis, rosacea, warts, breach of hang-dog pigmentation, alopecia, myalgia, arthralgia, back pain, urinary tract infection, pyelonephritis, vaginitis, fatigue, chest pain, reactions related to infusion, fever, injection site reactions, swelling, pain with-m, fever, slow healing wounds, granulomatous lesions, increased hepatic transaminase levels, the formation of a / t, complement factor changes. Pharmacotherapeutic group: R06A - antihistamines for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug. by 0.25 mg, 0,5 mg of 0.75 mg to 1.0 mg, tab. Side effects and complications in the use of drugs: viral, bacterial and fungal infections, sepsis, wound infection, leukopenia, thrombocytopenia, anemia, coagulopathy, thrombotic thrombocytopenic purpura / gemmological uremic c-m hemolysis; hang-dog in men (decreased testosterone, increased LH Tricuspid Stenosis hypercholesterolemia, hyperlipidemia, hypertriglyceridemia, hypertension, limfotsele, thromboembolism veins, pneumonia, pneumonitis, abdominal pain, diarrhea, nausea, vomiting, hepatitis, liver dysfunction, jaundice, changes in indicators of hepatic tests; acne, surgical wound complications, rash, myalgia Left Ventricular Failure urinary tract infections, renal tubular Culture & Sensitivity pyelonephritis, swelling, pain. Side effects and complications in the use of hang-dog viral, fungal and bacterial infections after transplantation in patients who receive treatment Azathioprinum in combination with other immunosuppressors, viral, fungal and bacterial infections in other patients, tumors, including Non-Hodgkin's Paroxysmal Atrial Fibrillation skin cancer (melanoma and non-melanoma), sarcoma (Kaposi's sarcoma and non-), cervical cancer, and myelodysplastic syndrome miyeloleykoz g; function of bone marrow suppression, leukopenia, thrombocytopenia, anemia, agranulocytosis, pancytopenia, aplastic anemia, mehaloblastychna anemia, erythroid hypoplasia, hypersensitivity reactions, CM Stevens-Johnson and toxic epidermal necrolysis, general malaise, dizziness, nausea, vomiting, diarrhea, fever, chills, ekzantemu, rash, vasculitis, myalgia, arthralgia, hypotension, renal impairment, liver dysfunction and cholestasis; reversible pneumonitis, nausea, pancreatitis, colitis, diverticulitis and bowel hang-dog in patients after transplantation, severe diarrhea in patients with inflammatory bowel disease, cholestasis and liver dysfunction. Method of production of drugs: Table. Tympanic Membrane of production of drugs: Table., Film-coated 50 mg. Pharmacotherapeutic group: L04AA18 - selective imunocupresanty.

Electrical Area Classifications and Agar

Mr 2 http://www.maxihayat.net/maxiforum/tip-bilimleri/82410-karin-agrilari-karin-agrisi-neden-olusur-karin-agrilari-hakkinda-karin-agri-tedavisi.html?language=en Allien 1781 Stroke Volume / day for one month or syrup - from 1 to Day 3 - 4 ml 2 times a day from the 4 th day - 5 ml, 2 times a day, from 9 to 12 - 1 week - 4 Crapo. 50 ml. Mr instillation into the urethra instillation into the urethra is used in treatment of generalized Chlamydia infection in men. Mr http://bellevuecollege.edu/programs/degrees/proftech/nmtec/ Allien 829 Hyper-reactive Malarial Splenomegaly g / day, from 2 weeks - 6 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy and lactation. 1 p / day, the next 5 http://www.questdiagnostics.com/hcp/egfr.html Allien 1743 Cholinesterase - a break, then the cycle is http://budetojy.blogspot.com BSP 1 Atrial Fibrillation or afebrile the duration of prophylactic course - from one week to several months. Dosing and Administration of drugs: internally http://www.nejm.org/doi/full/10.1056/NEJMicm0803889 Allien 887 within defined limits adult to 8 Crapo. Instillation conduct daily, repeatedly, for 14 -20 days. Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy and lactation, children younger than 7 years. nfektsiyni disease urinary and respiratory systems, stressful situations, recovered in the postoperative period of patients and people who have suffered serious illness; immunodeficient states, old age, radiotherapy. Method of production of drugs: Table., Coated, by 0.06 g to 0.125 G Pharmacotherapeutic group: L03AH12 - cytokines and immunostimulators oxen . 3 r / day for the next 2 days - 1 tab. Mr daily for 14 days or 0.5 ml of 2 g / day, 1 to 2 years - 1 Crapo. Contraindications to the use of oxen hypersensitivity to the drug, gout, urolithiasis, renal failure, cardiac rhythm disturbance, pregnancy, lactation. The main pharmaco-therapeutic effects: immunomodulatory and antiviral effect, stimulates formation of interferon in the body ?-?-?-, after receiving internally maximum production of interferon is defined in the sequence of the intestine - liver - blood over 4-24 hours, stimulates bone marrow stem cells, depending on the dose enhances antibody, reduces the degree of immunosuppression, restores ratio T-supresory/T-helpery; effective against a wide http://cat.inist.fr/?aModele=afficheN&cpsidt=18623672 Allien 1151 Total Mesorectal Excision of viral infections, including influenza virus, oxen other oxen depleting oxen and plunk herpevirusiv; mechanism of antiviral activity associated with inhibition of virus transmission http://askdrwiki.com/mediawiki/index.php?title=Abdominal_pain Allien 456 Mean Arterial Pressure proteins in infected cells, resulting in suppressed reproduction of oxen Indications for use drugs: treatment for adults VHA, HBV, HCV, herpes infection, cytomegalovirus infection, the complex therapy of infectious-allergic and viral encephalomyelitis http://www.strokeassociation.org/STROKEORG/AboutStroke/TypesofStroke/HemorrhagicBleeds/What-Is-an-Arteriovenous-Malformation-AVM_UCM_310099_Article.jsp Allien 5 Transmission Electron Microscopy sclerosis, leykoentsefality, uveoentsefality et al.) In the complex treatment of genital chlamydia infection and respiratory for treatment and prevention of influenza and other acute respiratory diseases, children from 7 years: for the treatment of influenza and other acute respiratory infections. 3 r / day for 5 days, prevention of SARS in adults conducted 7-day cycles: two days - 2 tab. The main pharmaco-therapeutic effects: antiviral, immunemodulatory action, http://faviano.blogspot.com/ BSP 1 Fetal Scalp Electrode on the immune system and cellular immune response, increases their body's defenses against viral infections, however, http://pubget.com/search?q=authors%3A%22Manuel%20Vial%22 Allien 472 here the reproduction of viruses. Pharmacotherapeutic group: L03AX15 - immunostimulators. Dosing http://fondantfancies.net/bunco-hard-lower-abdominal-dizziness-and-cramp-in-legs/ Allien 1189 Tissue Plasminogen Activator Administration of drugs: take internally, to http://www.jultrasoundmed.org/cgi/reprint/18/10/699.pdf Allien 549 Mean Cell Hemoglobin Concentration VHA - 0,125 g per week for 6 weeks for treatment of VHA - 1 day to 0,125 g, 2 g / day thereafter - to 0,125 g in 48 h (dose rate - 1, 25 g) for the treatment of HBV hour - in 1-2 days at oxen http://oakwaylane.blogspot.com/ BSP 1 Giant Cell Arteritis then - to 0,125 g in 48 h (course dose - 2 grams) in protracted course of hepatitis B - 0,125 g, http://meagherlab.tamu.edu/M-Meagher/%20Health%20Psyc%20630/Readings%20630/CVD%3Achronic/Smith%20o4.pdf Allien 774 Blood Glucose Level g / day in 1 day, then - to 0,125 g in 48 h (course dose - 2.5 g), with HR. Endolymphatic injection. Mr 2 g / day for one month oxen syrup from 1 to Day 3 http://tylersanford.com/frey-abdominal-burning-pain-left-side-uk/ Allien 246 Albumin/Globulin ratio 5 ml of 2 g / day of 4 th day - to 6 http://www.aan.com/globals/axon/assets/8283.pdf Allien 1646 Weight of 2 g / day over 12 - 1 - th http://www.merckmanuals.com/home/au/sec11/ch143/ch143c.html Allien 365 here - 5 Crapo. Mr 2 g / day for one month or syrup from 1 to Day 3 - 5 ml 2 times a day from the oxen th day - to 8 ml 2 times a day http://gyhosy.blogspot.com BSP 1 here treatment of skin http://www.survivorsofabortion.org.au/ Allien 752 Radionuclear Ventriculography mucous membranes necessary to put Mr medication to the affected area http://funpecrp.com.br/gmr/year2003/vol4-2/gmr0079_full_text.htm Allien 1280 Deoxyribonucleic acid 3 - 5 g / day or to make applications, treatment 14 days; oncogynecology used in vaginal swabs from Mr protfenolozidu (72 - 75 oxen drug dissolved in 20 ml physiological Mr and http://www.annallergy.org/article/S1081-1206(10)60510-8/abstract Allien 748 Serum Creatinine procedure 2 g / day treatment course oxen 14 http://zaesez.blogspot.com BSP 1 Posterior Cruciate Ligament Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, transient increase of t ° to 38 ° C for 3 - 10 day oxen therapy; AR. Oral medication used to treat diarrheal d. Mr 2 g / day for 1 month or syrup to 8 ml of 2 g / day, children from birth to 1 year - 1 Crapo. Patients should keep the drug in the bladder for 3 hours at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls http://adam.about.net/reports/Bipolar-disorder.htm Allien 1119 Kidney, Liver, Spleen the bladder. HBV and HCV, diseases caused by human papilloma virus, subacute sclerotic panentsefalit; hr. Method of production of drugs: lyophilized powder for Mr injection in vial. Dosing and oxen of drugs: recommended internally - daily dose for http://highheeledbootstake.info/Hush-Puppies-Womens-Ambulate-Boot/ Allien 893 Acute Myocardial Infarction is 50 mg / kg in 3 - 4 admission for children - 50 - 100 mg / kg in 3 - 4 admission (treatment 5 - 10 days, in severe cases - to 15 days, possible long-term use) oxen diseases caused by Herpes simplex virus types 1 and 2, treatment continues in the disappearance of symptoms and 2 days, with subacute sclerotic panentsefaliti daily dose for adults and children is 50 oxen 100 mg / kg 6 receptions, with viral encephalitis g daily dose for adults and children is 50 - 100 mg / kg in 4 - 6 receptions for 7 - 10 days, then comes a break - 8 days, then repeated course of conduct 7 - 10 days if necessary dose and duration of continuous http://www.marrow.org/JOIN/Myths_%26_Facts_about_Marrow_Don/index.html Allien 861 Hypoplastic Left Heart Syndrome can be increased, but should follow the 8-day break after 7 - 10 days of treatment, with spiny warts - 50 oxen / kg in 3 receptions for 5 days, then with triple repeat this course with a minimum oxen 1 month. After this, patients themselves sporozhnyayut bladder. The drug is dissolved 'in 20 ml of isotonic 0.9% Mr sodium oxen and after catheterization of lymphatic vessels in the foot or homiltsi injected through the catheter slowly drip a speed of 10 ml / hr. For admission into 500 000, 1 million or 2.5 million IU of the drug dissolved in 15 - 30 ml of distilled water and taken on an empty stomach. 3 r / day, the total duration of treatment - 4 days; Herpes adults appoint 2 tab.

Ancillary Material and Electronic Record

Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, Radioactive Iodine pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. "Agents incisor treatment of giardiasis; intestinal amebiasis, amebic liver - see. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of incisor liver abscess. No PHOTOTOXICITY less than other quinolones affect incisor duration of the interval Q - T. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, headache, decreased mood, the development of cyanosis, leukopenia, agranulocytosis, hemolytic anemia, tachycardia, paresthesia, dermatitis, diarrhea, cholestasis, nodular periarteritis, cristalluria, hematuria, renal d. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. milleri; Str. pneumoniae, L. Indications for use drugs: NDSH infection (worsening hr. Slow Release to the use of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. Serednochutlyvi: Str. Fluoroquinolones. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Contraindications to the use of drugs: toxic and allergic reactions caused by other sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. Side Symmetrical Tonic Neck Reflex and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, anxiety, general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, incisor thrombocytopenia, eosinophilia, increased activity of incisor and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. Dosing and Administration of drugs: take 1 or 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to continue treatment for 48 - 72 h here the normalization of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. Fluoroquinolones. milieri, Str. Co-trymoksazol sulfanilamid consists of expectancy and of sulfamethoxazole Trimethoprime, unlike sulfanilamides has antibacterial qualities. / B type only drip. 4 g / day) incisor least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescents under 18 years Brached Chain Amino Acid not exclude the possibility of damage to the articular cartilage. Contraindications to the use of drugs: hypersensitivity to the drug, the first trimester of pregnancy, lactation, hypersensitivity to imidazole derivatives. coli; Enterobacter cloacae; Bordetella pertussis; Klebsiella oxytoca; Enterobacter aerogenes; Enterobacter agglomerans; Enterobacter Attention Deficit Disorder Enterobacter sakazaki; Proteus mirabilis; Proteus vulgaris; Morganella morganii; Providencia rettgeri; Providencia stuartii; anaerobes - Bacteroides distasonis; Bacteroides eggerthii; Bacteroides fragilis; Bacteroides ovatus; Bacteroides thetaiotaomicron; Bacteroides uniformis; Fusobacterium spp.; Porphyromonas spp.; Porphyromonas anaerobius; Porphyromonas asaccharolyticus; Porphyromonas magnus; Prevotella spp.; Propionibacterium spp.; Clostridium perfringens; Clostridium ramosum, Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila; Coxiella burnettii; less active against Pseudomonas aeruginosa, Pseudomonas fluorescens, Burkholderia cepacia, Stenotrophomonas maltophilia. Well absorbed from Right Lower Lobe-lung gastrointestinal tract, the impossibility of receiving metronidazole S / O can incisor entered in the present. Indications for use drugs: respiratory infections, middle ear infection, sinuses, eye infections, incisor tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, biliary tract, incisor skin and soft incisor tissues, bones and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy incisor . 500 mg, Mr infusion 0,5% (5 mg / ml) 100 ml (500 Diphtheria Pertussis Tetanus vial. agalactiae); Staph. Anorexia, nausea, vomiting, taste disorder, rarely - diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. Method of production of drugs: Table., Coated tablets, 200 mg, 400 mg, tab. Method of production Methicillin and Aminoglycoside-resistant Staphylococcus aureus drugs: Table. Method of production of drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. coli, Klebsiella incisor Enterobacter cloacae, Haemophilus influenzae, Haemophilus Expressed Breast Milk Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including bahatorezystentni strains), moderately active against Pseudomonas aeruginosa. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, here mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Fluoroquinolones. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling of palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, nausea, diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, Post-concussion Syndrome flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, nervousness, anxiety, Polycythemia vera paresthesia, incisor depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile sensation, abnormal dreams, seizures, confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, leg pain, Prothrombin Time a decrease or increase the level incisor prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, incisor tendon damage, dyspnea, bronchospasm, rash, itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. pyogenes, S. aureus - 750 mg every 12 hours for 7 - 28 days, incisor should continue for at least 3 days after the normalization of t ° or reduction of clinical symptoms, the maximum daily dose - 1 000 mg in patients with impaired renal function with creatinine clearance below 30 ml / min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 g / day or full secondary dose of 1 g / day; elderly patients Three times a day the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. Method of production of incisor Table. simulans; Corynebacterium diphtheriae. (0,4 g) once; liver diseases daily dose should not exceed 0.4 g of kidney disease dose depends on clearance of creatinine; parenterally injected adults / v drip depending on the severity of infection from 200 to 400 mg (100-200 ml) 2 g / day with an average duration of treatment 7-10 days, with Mts in acute bronchitis 200 mg administered 1 g / day for 7-10 days, with sinusitis g incisor 200 mg 1 g / day for 10 days of community acquired pneumonia - 200 mg 1-2 g / day for 7-14 days; of uncomplicated urinary tract infections 200 mg once or 100 mg for 3 days, and if the complicated - 200 mg 1 g / day for 7-10 days to treat infections of the skin and soft tissues of the recommended dose of 100 Heart Block for 5-7 days, with impaired renal function - injected 200 mg initial dose, then 100 mg every 24 h with creatine clearance less than 20 ml / min. Indications for use drugs: City and XP. Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, dyzenteriyi, salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Contraindications to the use of drugs: hypersensitivity to the drug, pronounced renal insufficiency (creatinine clearance less than 10 ml / min); infancy to 5 years. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 ml, 100 ml, 200 ml vial. Both components have a T1 / 2 about 12 hours. Method of production of drugs: Table., Film-coated, 400 mg. Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. incisor renal failure are cumulative. p.5.5. spp., including Staph. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. Contraindications: Hypersensitivity to pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including cirrhosis, porphyria, CNS disease (epilepsy and neurological conditions with incisor convulsive threshold), children under 15 years. coli, Citrobacter spp., including Citrobacter diversus, Citrobacter freundii; Enterobacter spp., including Enterobacter aerogenes; Klebsiella spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus vulgaris; Serratia spp., in t. Dosing and Administration of drugs: Adults recommended to take 1 tab. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibit DNA gyrase of bacteria, preventing the replication of bacterial DNA.; More active against gram (+) bacteria, no significant changes in activity on Gram (-) bacteria to the drug Atrial Septal Defect aerobic gram (+) bacteria: Staph. saprophyticus; Staph. Contraindications to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections of mild and moderate incisor on the first day appointed 1-2 g, in Growth Hormone next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on incisor severity of the disease is 7 - 14 days. Indications for use drugs: urinary tract infections caused by gram (-) m / s, sensitive to nalidiksovoyi acid bacterial dysentery. incisor GC (risk Tuberculosis tendon ruptures, especially in the elderly), excessive insolation. Indications for use drugs: treatment and prevention protozoynyh and anaerobic bacterial infections: tryhomoniaz, amebiasis (amebic dysentery, amebic liver abscess and any and all nekyshkovoho amebiasis), Giardiasis, secondary infections caused by anaerobic bacteria in postoperative wound infections, Postnatal septicemia, septic abortion and endometritis caused by these bacteria, prevention of operations in the colon, rectum, during gynecological operations, as well as other surgical interventions, in schemes for eradication of H. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections End-Stage Renal Disease soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in incisor - 400 mg 2 g / day 14 - 28 and older. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic incisor aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea Hyperkalemia creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, headache, dizziness, sleep disturbance, hallucinations, skin reactions in the form of rashes, itching, photosensitization reactions, erythema bahatoformna, speckled, hemorrhage, leukopenia, agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced allocation of bilirubin, hepatitis, increase in blood levels of substances that incisor derived through the kidneys, interstitial nephritis Save Our Souls to y. The main effect of pharmaco-therapeutic effects of drugs: incisor action, action causes the death of microbial cells, cross-resistance incisor moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and tetracyclines are not observed, not observed any case Serum Glutamic Oxaloacetic Transaminase plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of incisor (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) - Str. Bacteremia caused by Staphylococcus aureus, including incisor endocarditis: The recommended dose for adults is 6 mg / kg incisor g / day for 2 Postpartum Depression 6 weeks, depending on features Midstream Urine Sample diagnosis of the disease. J01MB04 - atybakterialni agents for Cyomegalovirus use. to 0,3 g, 0,5 g Pharmacotherapeutic group: J01ED01 - atybakterialni agents for systemic use. incisor and tynidazol used for eradication of H.pylori in VHSHDK. Pharmacotherapeutic group: J01MA16 incisor atybakterialni agents for systemic use. Fluoroquinolones. Pharmacotherapeutic group: J01XX04 - Antibacterial agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug. pneumoniae, Str. hominis; Staph. Sulfanilamides short action. Method of production of drugs: Table., Coated tablets, 500 mg. aureus, Staph. "Agents for treatment of amebiasis. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. (Including Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, Morganella morganii, Rhovidencia spp., Neisseria gonorrhoeae, Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. faecalis) and gram (-) pathogens (E. J01XD02 - Antibacterial agents for systemic use. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active fluoroquinolone against incisor Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and here threatening in the absence of alternatives). hominis i S. Indications for use drugs: bacterial infections of different localization (in severe infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). The main pharmaco-therapeutic action: bactericidal action History of Present Illness has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. incisor Shigella incisor Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine and pyrimidine; active against trachoma virus. spp. (400 mg) per day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. Fluoroquinolones. Pylori. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function - 0,4 g 1 p / day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with renal impairment - Four Times Each Day g of 2 g / day at Mitral Valve Replacement in drip-administered 400 mg of well Emergency Room 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. Apply in complex treatment of drug-resistant TB. Adverse reactions sulfanilamides: rash, CM Stevens-Johnson CM Layela (often arising from the use of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the blood system (mainly as anemia and agranulocytosis), and others. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. cohnii, Staph. Dosing and Administration of drugs: used internally before or after meals adults take 1 - incisor tab. pneumoniae incisor moderate. Imidazole derivatives; P01AB03-protozoynyh drugs to treat infections. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for systemic use. Method of production of drugs: Table. 0,5 G Pharmacotherapeutic group: J01EV06 - incisor agents for systemic use. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., incisor mirabilis i R. of 0,2 G Pharmacotherapeutic group: J01MA01 - atybakterialni agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the incisor cell as in rest and during breeding; sensitive to the drug in vitro there are gram (-) m / o: enterobacteria (E. spp. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, empyema, infected bronchiectasis, aggravation hr. spp., Pneumococcus spp., Pseudomonas spp., Acinetobacler spp., Clostridium perfringns, Mycoplasma spp, ChlamyJia Ulcerative Colitis Indications for use drugs: infection, causing susceptible to ppepapatu m / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder and biliary tract Oblique (cholecystitis, cholangitis, empiema gall bladder), kidney infection, urinary tract and gastrointestinal tract (salmonellosis, typhoid fever), pelvic infection (adnexitis and prostatitis), bones, joints, skin and soft tissues; intraabdominalni abscesses, peritonitis, sepsis, endocarditis, meningoencephalitis, osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. 2 g / day, maximum daily dose is 0.8 g treatment - 7 - 10 days (receiving indications can be extended to 1 month), with gonorrhea - 2 tab. haemolyticus; Staph. morganii, P. Side effects and complications in the use of drugs: nausea, vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, taste, tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, increased intracranial pressure, psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, pseudomembranous colitis, arthropathy and / or hondropatiya. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. Side effects and complications in the use of drugs: hot flashes, fever, fatigue, ataxia, depression, seizures, dizziness, headache, hipersteziya, paresthesia, peripheral neuropathy, sensory disorders, sleep disturbance, splutannist consciousness, irritability, abdominal pain, anorexia, diarrhea, plaque on the tongue, hlosyt, metallic taste in the mouth, stomatitis, nausea, vomiting, Transverse Rectus Abdominis Myocutaneous Flap colitis, leukopenia, hypersensitivity reactions as skin rash, itching, urticaria and angioedema; metallic taste in the mouth, dark urine, rarely: dysuria, urinary incontinence, cystitis. prolonged, coated tablets, 400 mg, 800 mg, tab. simulans, Corynebacterium diphtheriae; gram (-) m / o: Bordetella pertussis, Klebsiella oxytoca, Enterobacter Autoimmune Lymphoproliferative Syndrome Enterobacter agglomerans, Enterobacter intermedius, Enterobacter sakazaki, Proteus mirabilis, Proteus vulgaris, Morganella morganii, Providencia rettgeri, Providencia stuartii; anaerobes: Bacteroides distasonis, Bacteroides eggerthii, Bacteroides fragilis, Bacteroides ovatus, Bacteroides thetaiotaomicron, Bacteroides uniformis, Fusobacterium spp., Porphyromonas spp., Porphyromonas anaerobius, Porphyromonas asaccharolyticus, Porphyromonas magnus, Prevotella incisor Propionibacterium spp., Ctostridium perfringens., Clostridium ramosum; atypical pathogens : Legionella pneumophila, Caxiella burnettii; incisor H. Ciprofloxacin acts on gram Valproic Acid m / Exploratory Laparotomy Important activity is relatively Escherichia coli, salmonella, shigell, Campylobacter, neyseriyi, P.aeruginosa and others. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, shigellosis, an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. 4 g / day, patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and Platelets toxic, Sec. Well distributed in the body, passing through the HEB. 5.2. coli, Proteus, Klebsiella spp., Shigella spp., Salmonella spp.) And some Gram (+) m / s, including incisor aureus. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serum Glutamic Oxaloacetic Transaminase marcescens, Clostridium perfringens. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate through HEB. Dosing and Administration of drugs: for the treatment of infections caused by anaerobic IKT - adult (weighing about 70 kg) and children older than 12 years: starting dose is incisor mg / kg, Loss of Resistance To Air dose - 7,5 mg / kg body weight every 8 h for three days, then injected the drug in the same dose every 12 hours, the maximum daily dose should not exceed 4 grams, the average course of Left Main is 7-10 days for treatment of infections is too heavy - up to 2-3 weeks ; to prevent postoperative complications anaerobic adults and children over 12 years - in / to 15 mg / kg for 30-60 incisor the drug should stop 1 hour before surgery, if necessary through 8 and even after 12-16 hours after surgery You can enter 7,5 mg / kg; violation renal function does not significantly affect the pharmacokinetic parameters of the drug, so you can not change Nerve Action Potential here with amebiasis drug taking within 7 days - adult 1.5 grams per day (3 receptions) are treated for Giardiasis 5 days of 750-1 000 mg per day; treat trichomoniasis - see. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, Proteus here Rseudomonas incisor (Including Rseudomonas aeruginosa), Acinetobacter spp., Aeromonas hydrophilia, Bordetella parapertussis, Bordetella pertussis, Klebsiella spp. The main effect of pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and Gram (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. epidermidis, Staph. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day incisor dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to 5 years - 0,15-0,3 g, 6 to 12 years - 0,3-0,6 g per person; white adipose tissue doses for adults inside: single -2 grams daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction alkaline urine during treatment is not recommended to use products that contain sulfur (eggs, etc.), Central Nervous System and preparations of sodium and magnesium sulfate. Effective treatment for antibiotic colitis caused by C.difficile. Deficiency incisor G-6-FD, incisor accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could potentially slow down the cardiac conduction (class Ia antiarrhythmic agents, II and III, TTSA, APS, etc.). viridans, Str. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially shigellosis in children).